Jérôme Bourgeais

635 total citations
20 papers, 359 citations indexed

About

Jérôme Bourgeais is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Jérôme Bourgeais has authored 20 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Hematology and 6 papers in Oncology. Recurrent topics in Jérôme Bourgeais's work include Acute Myeloid Leukemia Research (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Mitochondrial Function and Pathology (3 papers). Jérôme Bourgeais is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Mitochondrial Function and Pathology (3 papers). Jérôme Bourgeais collaborates with scholars based in France, Austria and United States. Jérôme Bourgeais's co-authors include Fabrice Gouilleux, Olivier Hérault, Valérie Gouilleux‐Gruart, Brigitte Sola, Emmanuel Gyan, Jorge Domenech, Richard Moriggl, Frédéric Mazurier, Florence Rouleux‐Bonnin and Florence Zylbersztejn and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and PLoS Biology.

In The Last Decade

Jérôme Bourgeais

19 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérôme Bourgeais France 11 187 116 99 66 65 20 359
Runxia Gu China 10 132 0.7× 64 0.6× 111 1.1× 48 0.7× 23 0.4× 41 412
Zakar Mnjoyan United States 8 167 0.9× 92 0.8× 58 0.6× 67 1.0× 21 0.3× 9 389
Toshie Gamou Japan 10 302 1.6× 157 1.4× 64 0.6× 52 0.8× 25 0.4× 15 434
Xiao Yan China 8 146 0.8× 85 0.7× 64 0.6× 36 0.5× 36 0.6× 22 315
Nisha Tapryal United States 11 257 1.4× 47 0.4× 50 0.5× 47 0.7× 28 0.4× 16 392
Iris Kaiser Germany 10 207 1.1× 79 0.7× 61 0.6× 28 0.4× 61 0.9× 11 414
Dongmei Guo China 13 276 1.5× 35 0.3× 77 0.8× 106 1.6× 20 0.3× 35 409
Heather Tibbles United States 14 119 0.6× 88 0.8× 90 0.9× 18 0.3× 56 0.9× 28 424
Lijun Wen China 9 210 1.1× 65 0.6× 19 0.2× 70 1.1× 29 0.4× 29 298
Elisa Ferrari Italy 7 268 1.4× 28 0.2× 89 0.9× 117 1.8× 21 0.3× 9 431

Countries citing papers authored by Jérôme Bourgeais

Since Specialization
Citations

This map shows the geographic impact of Jérôme Bourgeais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Bourgeais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Bourgeais more than expected).

Fields of papers citing papers by Jérôme Bourgeais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Bourgeais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Bourgeais. The network helps show where Jérôme Bourgeais may publish in the future.

Co-authorship network of co-authors of Jérôme Bourgeais

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Bourgeais. A scholar is included among the top collaborators of Jérôme Bourgeais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Bourgeais. Jérôme Bourgeais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chevaleyre, Claire, Anthony Estienne, Jérôme Bourgeais, et al.. (2024). The hepatokine FGF21 stopped lipogenesis and reduced testosterone production in mLTC-1 Leydig Cell Line. Molecular and Cellular Endocrinology. 594. 112350–112350.
2.
Crottès, David, Jérôme Bourgeais, Naïg Guéguen, et al.. (2024). MICU2 up-regulation enhances tumor aggressiveness and metabolic reprogramming during colorectal cancer development. PLoS Biology. 22(10). e3002854–e3002854. 1 indexed citations
3.
4.
Lanznaster, Débora, Clément Bruno, Jérôme Bourgeais, et al.. (2022). Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis. Biomedicines. 10(6). 1307–1307. 11 indexed citations
5.
Picou, Frédéric, Nathalie Gallay, Jérôme Bourgeais, et al.. (2021). Low-Dose Pesticides Alter Primary Human Bone Marrow Mesenchymal Stem/Stromal Cells through ALDH2 Inhibition. Cancers. 13(22). 5699–5699. 10 indexed citations
6.
Vignon, Christine, Christelle Debeissat, Jérôme Bourgeais, et al.. (2020). Involvement of GPx-3 in the Reciprocal Control of Redox Metabolism in the Leukemic Niche. International Journal of Molecular Sciences. 21(22). 8584–8584. 7 indexed citations
7.
Bourgeais, Jérôme, Nathalie M. Mazure, Eric Lelièvre, et al.. (2020). Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells. Oncogenesis. 9(7). 68–68. 27 indexed citations
8.
Fabbri, Lucilla, Maeva Dufies, Sandra Lacas‐Gervais, et al.. (2020). Evidences of a Direct Relationship between Cellular Fuel Supply and Ciliogenesis Regulated by Hypoxic VDAC1-ΔC. Cancers. 12(11). 3484–3484. 10 indexed citations
9.
Hergesheimer, Rudolf, Débora Lanznaster, Jérôme Bourgeais, et al.. (2020). Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient Cells. Cells. 9(10). 2198–2198. 8 indexed citations
10.
11.
Lanznaster, Débora, Jérôme Bourgeais, Clément Bruno, et al.. (2019). TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis. Cells. 9(1). 68–68. 7 indexed citations
12.
Picou, Frédéric, Christelle Debeissat, Jérôme Bourgeais, et al.. (2018). n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation. Pharmacological Research. 136. 45–55. 28 indexed citations
13.
Friedbichler, Katrin, Cédric Boudot, Jérôme Bourgeais, et al.. (2017). STAT5A/5B-specific expansion and transformation of hematopoietic stem cells. Blood Cancer Journal. 7(1). e514–e514. 5 indexed citations
14.
Bourgeais, Jérôme, Jean‐Claude Chomel, Ali G. Turhan, et al.. (2017). Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis. Stem Cells and Development. 26(10). 709–722. 36 indexed citations
15.
Bourgeais, Jérôme, et al.. (2017). New Inhibitor Targeting Signal Transducer and Activator of Transcription 5 (STAT5) Signaling in Myeloid Leukemias. Journal of Medicinal Chemistry. 60(14). 6119–6136. 19 indexed citations
16.
Bourgeais, Jérôme, Magdalena Medrzycki, Valérie Gouilleux‐Gruart, et al.. (2016). Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses. Oncotarget. 8(26). 41876–41889. 32 indexed citations
17.
Bourgeais, Jérôme, et al.. (2016). Cyclin D1 unbalances the redox status controlling cell adhesion, migration, and drug resistance in myeloma cells. Oncotarget. 7(29). 45214–45224. 23 indexed citations
18.
Bourgeais, Jérôme, Valérie Gouilleux‐Gruart, & Fabrice Gouilleux. (2013). Oxidative metabolism in cancer. PubMed. 2(4). e25764–e25764. 44 indexed citations
19.
Berger, Angelika, Andrea Hoelbl‐Kovacic, Jérôme Bourgeais, et al.. (2013). PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis. Leukemia. 28(3). 629–641. 46 indexed citations
20.
Debuysscher, Véronique, Jérôme Bourgeais, Cédric Boudot, et al.. (2012). Evidence for a protective role of the STAT5 transcription factor against oxidative stress in human leukemic pre-B cells. Leukemia. 26(11). 2390–2397. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Runxia Gu Breakdown of academic impact, for papers by Zakar Mnjoyan Breakdown of academic impact, for papers by Toshie Gamou Breakdown of academic impact, for papers by Xiao Yan Breakdown of academic impact, for papers by Nisha Tapryal Breakdown of academic impact, for papers by Iris Kaiser Breakdown of academic impact, for papers by Dongmei Guo Breakdown of academic impact, for papers by Heather Tibbles Breakdown of academic impact, for papers by Lijun Wen Breakdown of academic impact, for papers by Elisa Ferrari
Rankless by CCL
2026